Editor: Jean-Marc Sabatier

Coronaviruses

Volume 1

eBook: US $39 Special Offer (PDF + Printed Copy): US $66
Printed Copy: US $47
Library License: US $156
ISSN: 2737-5625 (Print)
ISSN: 2737-5633 (Online)
ISBN: 978-981-14-9894-7 (Print)
ISBN: 978-981-14-9896-1 (Online)
Year of Publication: 2021
DOI: 10.2174/97898114989611210101

Introduction

In this difficult period of the SARS-CoV-2 (and its variants) infection responsible for Covid-19 diseases, the importance of scientific works and reviews dealing with these viruses has never been more essential and vital. Reports as of 20th April 2021 indicate over 141 million cases of SARS-CoV-2 infection worldwide (with over 3 million deaths recorded). This volume brings together essential data regarding prevention (vaccination), detection, and various approaches (chemotherapeutic drugs and antibodies) to the potential treatment of coronavirus infections. It presents six chapters concerning the following topics:

(1) the resistance to the spread of SARS-CoV-2 and related Covid-19 diseases within a population based on the pre-existing immunity of a high proportion of individuals as a result infection or previous vaccination

(2) the impact of the Covid-19 pandemic for the South Asian Association for Regional Cooperation (SAARC) region, comprising the Bangladesh, Bhutan, Maldives, Nepal, Pakistan, Sri Lanka, India, and Afghanistan

(3) the effect of candidate drugs chloroquine and hydroxychloroquine on QT interval in infected patients with Covid-19 diseases

(4) the antiviral potential of herbal-based immunomodulators

(5) the humoral immune response in humans based on anti-SARS-CoV-2 antibodies to treat Covid-19 diseases

(6) the various methods and strategies for diagnosing SARS-CoV-2 (and its variants) infection in hosts/humans.

This compilation should prove to be a tool of crucial importance for researchers around the world working on research revolving around coronaviruses, as well as for clinicians confronted by a growing number of patients with COVID-19.

Preface

In this difficult period of the SARS-CoV-2 (and its variants) infection responsible for Covid-19 diseases, the importance of scientific works and reviews dealing with these viruses has never been more essential and vital. This book brings together essential data regarding prevention (vaccination), detection, and various approaches (chemotherapeutic drugs and antibodies) to the potential treatment of coronavirus infections. It consists of six chapters concerning, (1) the effect of candidate drugs chloroquine and hydroxychloroquine on QT interval in infected patients with Covid-19 diseases (chapter 1 by Aleem et al.), (2) the impact of the Covid-19 pandemic for the South Asian Association for Regional Cooperation (SAARC), comprising the Bangladesh, Bhutan, Maldives, Nepal, Pakistan, Sri Lanka, India, and Afghanistan (Chapter 2 by Kanwar et al.), (3) the humoral immune response in humans based on anti-SARS-CoV-2 antibodies to treat Covid-19 diseases (chapter 3 by Çalık1 et al.), (4) the antiviral potential of herbal-based immunomodulators (chapter 4 by Kumari et al.), (5) the various methods and strategies for diagnosing SARS-CoV-2 (and its variants) infection in hosts/humans (Chapter 5 by Narvekar et al.), and (6) the resistance to the spread of SARS-CoV-2 and related Covid-19 diseases within a population based on the pre-existing immunity of a high proportion of individuals as a result infection or previous vaccination (chapter 6 by Tiwari & Sahu). Such a book comprising a compilation of key data on SARS-CoV-2 and Covid-19 should certainly be a tool of crucial importance for researchers around the world working on these research themes, as well as for clinicians confronted to a growing number of patients with Covid-19 (data from 20th April 2021: 141 million cases of SARS-CoV-2 infection worldwide, with over 3 million deaths).

Jean-Marc Sabatier
Institute of NeuroPhysiopathology
Marseille, Cedex
France

RELATED BOOKS

.Influenza: A Century of Research.
.Frontiers in Clinical Drug Research-Anti-Infectives.
.Histopathological Diagnosis of Leprosy.
.COVID-19: Diagnosis and Management-Part II.